Ideal Ferritin Level for a 36-Year-Old Woman
For a healthy 36-year-old woman, maintaining a serum ferritin level above 30 ng/mL is ideal to prevent iron deficiency and its associated symptoms, with levels below this threshold indicating iron deficiency that warrants evaluation and treatment.
Evidence-Based Thresholds
The most recent 2026 American Society of Hematology (ASH) guidelines provide clear diagnostic thresholds that directly inform what constitutes "ideal" ferritin levels 1:
For Menstruating Women (Most Applicable)
- Ferritin ≤30 ng/mL = Iron deficiency 1
- Ferritin ≤50 ng/mL = Iron deficiency in higher-risk scenarios including:
- Heavy menstrual bleeding or abnormal uterine bleeding
- Symptoms of iron deficiency (fatigue, decreased cognition, restless legs, decreased exercise tolerance)
- Additional risk factors (vegetarian diet, blood donation, GI conditions, PPI use)
- Planning pregnancy or upcoming surgery 1
Clinical Interpretation
The "ideal" ferritin level is therefore >30 ng/mL at minimum, and >50 ng/mL for women with any risk factors or symptoms. This represents the threshold above which iron stores are considered adequate to prevent iron-deficient erythropoiesis and associated morbidity.
Why These Thresholds Matter for Quality of Life
The ASH guidelines explicitly prioritize these higher thresholds (30-50 ng/mL vs. the outdated 15 ng/mL) because missing iron deficiency leads to significant adverse health consequences 1:
- Fatigue and decreased quality of life
- Impaired cognitive function and altered mood
- Decreased physical performance and exercise tolerance
- Restless legs syndrome
- Risk of progression to iron deficiency anemia
- Increased bleeding risk with surgery
- Potential complications if pregnancy occurs
Physiologic Evidence Supporting These Thresholds
Recent physiologically-based research validates these cutoffs. A 2021 NHANES study using objective markers of iron-deficient erythropoiesis (hemoglobin and soluble transferrin receptor) identified a ferritin threshold of 25.2 μg/L for non-pregnant women as the point where iron-deficient erythropoiesis begins 2. This provides independent physiologic confirmation that the ASH threshold of ≤30 ng/mL appropriately identifies clinically significant iron deficiency.
Context-Specific Considerations
If She Has Risk Factors
A ferritin >50 ng/mL should be the target if your patient has 1:
- Heavy or prolonged menstrual periods
- Vegetarian/vegan diet
- Regular blood donation
- History of GI conditions (GERD, celiac, IBD)
- Long-term PPI or antacid use
- High-intensity exercise
- Plans for pregnancy or surgery
If She Is Asymptomatic and Low-Risk
A ferritin >30 ng/mL is adequate for a healthy woman without symptoms or risk factors 1.
Common Pitfalls to Avoid
Don't use outdated thresholds: The old cutoff of 15 ng/mL misses a substantial proportion of women with iron deficiency who would benefit from treatment 1.
Check for inflammation: Ferritin is an acute phase reactant. If C-reactive protein is elevated, ferritin may be falsely normal despite true iron deficiency. In this scenario, add transferrin saturation (<20% suggests iron deficiency) 1.
Don't ignore symptoms: Even with ferritin 30-50 ng/mL, if she has fatigue, cognitive symptoms, or other iron deficiency manifestations, consider treatment 1, 3.
Laboratory reference ranges are misleading: Most lab-reported "normal" ranges have lower limits of 10-15 ng/mL for women, which are not evidence-based and contribute to systematic underdiagnosis 4. Use the clinical decision limits of 30-50 ng/mL, not the lab reference range.
Practical Algorithm
For a 36-year-old woman:
Measure ferritin (and CRP if available to exclude inflammation)
Interpret results:
- Ferritin ≤30 ng/mL → Iron deficiency present, evaluate and treat
- Ferritin 31-50 ng/mL + risk factors or symptoms → Consider iron deficiency, evaluate and treat
- Ferritin >50 ng/mL → Adequate iron stores
If treating, reassess in 8-10 weeks to confirm response 5
The ideal ferritin level is therefore >30 ng/mL as a baseline, with >50 ng/mL preferred for women with any additional risk factors, symptoms, or future pregnancy plans.